Lv11
36 积分 2024-07-09 加入
Advances in the management of peritoneal malignancies
1小时前
待确认
SOCS3 inhibiting JAK-STAT pathway enhances oncolytic adenovirus efficacy by potentiating viral replication and T-cell activation
1个月前
已完结
Navigating metabolic pathways to enhance antitumour immunity and immunotherapy
4个月前
已完结
Biological and clinical significance of tumour-infiltrating lymphocytes in the era of immunotherapy: a multidimensional approach
4个月前
已完结
Antiangiogenic–immune-checkpoint inhibitor combinations: lessons from phase III clinical trials
4个月前
已完结
Doxorubicin–Trabectedin with Trabectedin Maintenance in Leiomyosarcoma
5个月前
已完结
Imlunestrant with or without Abemaciclib in Advanced Breast Cancer
5个月前
已完结
Clinical and translational advances in ovarian cancer therapy
5个月前
已完结
PD-L1 as a biomarker of response to immune-checkpoint inhibitors
6个月前
已完结
Genomic and immune signatures predict clinical outcome in newly diagnosed multiple myeloma treated with immunotherapy regimens
6个月前
已完结
皖公网安备34019202002308
